Merck’s Covid-19 Medicine Viewed As ‘Huge Advance’ As It Could Half Deaths From The Disease
According to data that experts praised as a possible milestone in how the Covid-19 causing virus is handled, an experimental antiviral medicine produced by Merck & Co has shown the potential to half the risks of dying or being hospitalised for people most at risk of acquiring severe case of Covid-19. If approved, molnupiravir, which…









